Rajesh Alajangi

Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy

Maria Gabelli, Macarena Oporto Espuelas, Saskia Burridge et al. · Blood Advances · 2023 · 26 citations · Full text

Life Sciences, Hematology, Immunology +16

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real‐world intention‐to‐treat analysis

Maeve O’Reilly, William Wilson, David Burns et al. · HemaSphere · 2024 · 22 citations · Full text

Medicine, Hematology, Oncology +16

Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme

Macarena Oporto Espuelas, Saskia Burridge, Amy A. Kirkwood et al. · Blood Cancer Journal · 2024 · 16 citations · Full text

Medicine, Hematology, Oncology +17

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy et al. · The Lancet Haematology · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacology +13